ArticleInfection and drug resistance2026
Enhanced Spread of Carbapenem-Resistant
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The transmission of carbapenem-resistant Methods: We routinely screened for Results: Among 1694 environmental samples, 40 (2.36%) samples were CRPA. In 1576 nasopharyngeal and rectal samples (from 353 patients), 108 samples (6.86%) were CRPA. Sequence type (ST) 463 was the most prevalent clone in both patient and environmental samples. Spatiotemporal distribution and genomic data revealed sporadic patients-related transmission before COVID-19 upsurge period, while high-risk ST463 clone transmission was detected during COVID-19 upsurge period. However, there was no strong evidence to show that antibiotic consumption significantly influenced CRPA transmission in this study. Additionally, the evolution events of Conclusion: Our prospective study demonstrates that COVID-19 upsurge is associated with increased
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.